Correlation Between AstraZeneca PLC and GW Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and GW Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and GW Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and GW Pharmaceuticals Plc, you can compare the effects of market volatilities on AstraZeneca PLC and GW Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of GW Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and GW Pharmaceuticals.

Diversification Opportunities for AstraZeneca PLC and GW Pharmaceuticals

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AstraZeneca and GWPH is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and GW Pharmaceuticals Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GW Pharmaceuticals Plc and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with GW Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GW Pharmaceuticals Plc has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and GW Pharmaceuticals go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and GW Pharmaceuticals

If you would invest  6,280  in AstraZeneca PLC ADR on December 29, 2023 and sell it today you would earn a total of  532.50  from holding AstraZeneca PLC ADR or generate 8.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  GW Pharmaceuticals Plc

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

3 of 100

 
Low
 
High
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in AstraZeneca PLC ADR are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, AstraZeneca PLC is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
GW Pharmaceuticals Plc 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days GW Pharmaceuticals Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, GW Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

AstraZeneca PLC and GW Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and GW Pharmaceuticals

The main advantage of trading using opposite AstraZeneca PLC and GW Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, GW Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GW Pharmaceuticals will offset losses from the drop in GW Pharmaceuticals' long position.
The idea behind AstraZeneca PLC ADR and GW Pharmaceuticals Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements